ITMI20040146A1 - Ibopamina maleato metodo per prepararlo e composizioni farmaceutiche che lo comprendono - Google Patents

Ibopamina maleato metodo per prepararlo e composizioni farmaceutiche che lo comprendono

Info

Publication number
ITMI20040146A1
ITMI20040146A1 IT000146A ITMI20040146A ITMI20040146A1 IT MI20040146 A1 ITMI20040146 A1 IT MI20040146A1 IT 000146 A IT000146 A IT 000146A IT MI20040146 A ITMI20040146 A IT MI20040146A IT MI20040146 A1 ITMI20040146 A1 IT MI20040146A1
Authority
IT
Italy
Prior art keywords
ibopamine
prepare
pharmaceutical compositions
bad method
bad
Prior art date
Application number
IT000146A
Other languages
English (en)
Inventor
Nicola Cazzolla
Caterina Maugeri
Mario Pinza
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Priority to IT000146A priority Critical patent/ITMI20040146A1/it
Publication of ITMI20040146A1 publication Critical patent/ITMI20040146A1/it
Priority to EP05706914A priority patent/EP1708988B1/en
Priority to AT05706914T priority patent/ATE502004T1/de
Priority to ES05706914T priority patent/ES2361520T3/es
Priority to DK05706914.8T priority patent/DK1708988T3/da
Priority to PCT/EP2005/000445 priority patent/WO2005075409A1/en
Priority to KR1020067015322A priority patent/KR101109566B1/ko
Priority to US10/586,865 priority patent/US7667069B2/en
Priority to AU2005211453A priority patent/AU2005211453B2/en
Priority to CNB2005800030862A priority patent/CN100564351C/zh
Priority to SI200531293T priority patent/SI1708988T1/sl
Priority to JP2006550016A priority patent/JP4646921B2/ja
Priority to BRPI0507153-4A priority patent/BRPI0507153A/pt
Priority to PT05706914T priority patent/PT1708988E/pt
Priority to CA2551411A priority patent/CA2551411C/en
Priority to EA200601117A priority patent/EA009212B1/ru
Priority to DE602005026909T priority patent/DE602005026909D1/de
Priority to PL05706914T priority patent/PL1708988T3/pl
Priority to IL176431A priority patent/IL176431A/en
Priority to HK06114155.6A priority patent/HK1093721A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/08—Mydriatics or cycloplegics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT000146A 2004-01-30 2004-01-30 Ibopamina maleato metodo per prepararlo e composizioni farmaceutiche che lo comprendono ITMI20040146A1 (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
IT000146A ITMI20040146A1 (it) 2004-01-30 2004-01-30 Ibopamina maleato metodo per prepararlo e composizioni farmaceutiche che lo comprendono
PL05706914T PL1708988T3 (pl) 2004-01-30 2005-01-13 Maleinian ibopaminy, sposób jego wytwarzania i zawierające go kompozycje farmaceutyczne
AU2005211453A AU2005211453B2 (en) 2004-01-30 2005-01-13 Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it
SI200531293T SI1708988T1 (sl) 2004-01-30 2005-01-13 Ibopamin maleat, postopek za njegovo pripravo in farmacevtski sestavki, ki ga vsebujejo
ES05706914T ES2361520T3 (es) 2004-01-30 2005-01-13 Maleato de ibopamina, procedimiento para su preparación y composiciones farmacéuticas que lo contienen.
DK05706914.8T DK1708988T3 (da) 2004-01-30 2005-01-13 Ibopaminmaleat, fremgangsmåde til dets fermstilling og farmaceutiske sammensætninger, der indeholder dette
PCT/EP2005/000445 WO2005075409A1 (en) 2004-01-30 2005-01-13 Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it
KR1020067015322A KR101109566B1 (ko) 2004-01-30 2005-01-13 이보파민 말레산염, 이의 제조 방법 및 이를 함유하는약학적 조성물
US10/586,865 US7667069B2 (en) 2004-01-30 2005-01-13 Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it
EP05706914A EP1708988B1 (en) 2004-01-30 2005-01-13 Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it
CNB2005800030862A CN100564351C (zh) 2004-01-30 2005-01-13 异波帕胺马来酸盐、其制备方法以及含有它的药物组合物
AT05706914T ATE502004T1 (de) 2004-01-30 2005-01-13 Ibopaminmaleat, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen, die dieses enthalten
JP2006550016A JP4646921B2 (ja) 2004-01-30 2005-01-13 マレイン酸イボパミンを含む医薬組成物及びその製造方法
BRPI0507153-4A BRPI0507153A (pt) 2004-01-30 2005-01-13 composto, composição farmacêutica para uso oftálmico, e, processo para a preparação do sal de maleato de ibopamina
PT05706914T PT1708988E (pt) 2004-01-30 2005-01-13 Maleato de ibopamina, m?todo para a sua prepara??o e composi??es farmac?uticas que o cont?m
CA2551411A CA2551411C (en) 2004-01-30 2005-01-13 Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it
EA200601117A EA009212B1 (ru) 2004-01-30 2005-01-13 Малеат ибопамина, способ его получения и фармацевтические композиции на его основе
DE602005026909T DE602005026909D1 (de) 2004-01-30 2005-01-13 Ibopaminmaleat, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen, die dieses enthalten
IL176431A IL176431A (en) 2004-01-30 2006-06-20 Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it
HK06114155.6A HK1093721A1 (en) 2004-01-30 2006-12-27 Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000146A ITMI20040146A1 (it) 2004-01-30 2004-01-30 Ibopamina maleato metodo per prepararlo e composizioni farmaceutiche che lo comprendono

Publications (1)

Publication Number Publication Date
ITMI20040146A1 true ITMI20040146A1 (it) 2004-04-30

Family

ID=34835573

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000146A ITMI20040146A1 (it) 2004-01-30 2004-01-30 Ibopamina maleato metodo per prepararlo e composizioni farmaceutiche che lo comprendono

Country Status (20)

Country Link
US (1) US7667069B2 (it)
EP (1) EP1708988B1 (it)
JP (1) JP4646921B2 (it)
KR (1) KR101109566B1 (it)
CN (1) CN100564351C (it)
AT (1) ATE502004T1 (it)
AU (1) AU2005211453B2 (it)
BR (1) BRPI0507153A (it)
CA (1) CA2551411C (it)
DE (1) DE602005026909D1 (it)
DK (1) DK1708988T3 (it)
EA (1) EA009212B1 (it)
ES (1) ES2361520T3 (it)
HK (1) HK1093721A1 (it)
IL (1) IL176431A (it)
IT (1) ITMI20040146A1 (it)
PL (1) PL1708988T3 (it)
PT (1) PT1708988E (it)
SI (1) SI1708988T1 (it)
WO (1) WO2005075409A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY31531A1 (es) * 2007-12-17 2009-08-03 Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
US20240065999A1 (en) * 2020-11-09 2024-02-29 The Board Of Trustees Of The Leland Stanford Junior University Ophthalmic Formulation Containing a Dopaminergic Prodrug that may be Combined with One or More Agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2400038A (en) * 1944-09-07 1946-05-07 Burroughs Wellcome Co Esters of secondary phenolic amines
IT1074038B (it) * 1976-08-05 1985-04-17 Simes Esteri della epinina
IT1178800B (it) 1984-12-27 1987-09-16 Simes Composizioni farmaceutiche e loro uso come midriatici
IT1231488B (it) 1988-11-09 1991-12-07 Zambon Spa Soluzione acquosa farmaceutica tamponata a ph 4,5 per uso oftalmico contenente ibopamina e idrossipropilmetilcellulosa
IT1247508B (it) * 1991-04-19 1994-12-17 Zambon Spa Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa

Also Published As

Publication number Publication date
CA2551411A1 (en) 2005-08-18
IL176431A0 (en) 2006-10-05
JP2007519657A (ja) 2007-07-19
ES2361520T3 (es) 2011-06-17
DK1708988T3 (da) 2011-06-27
KR101109566B1 (ko) 2012-01-31
EP1708988B1 (en) 2011-03-16
JP4646921B2 (ja) 2011-03-09
AU2005211453A1 (en) 2005-08-18
EA200601117A1 (ru) 2006-10-27
EA009212B1 (ru) 2007-12-28
EP1708988A1 (en) 2006-10-11
CN100564351C (zh) 2009-12-02
CA2551411C (en) 2012-04-24
US7667069B2 (en) 2010-02-23
WO2005075409A1 (en) 2005-08-18
SI1708988T1 (sl) 2011-06-30
CN1910139A (zh) 2007-02-07
DE602005026909D1 (de) 2011-04-28
AU2005211453B2 (en) 2011-06-30
KR20060127940A (ko) 2006-12-13
BRPI0507153A (pt) 2007-07-31
US20080242724A1 (en) 2008-10-02
PL1708988T3 (pl) 2011-08-31
HK1093721A1 (en) 2007-03-09
IL176431A (en) 2010-11-30
ATE502004T1 (de) 2011-04-15
PT1708988E (pt) 2011-05-31

Similar Documents

Publication Publication Date Title
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
CA2672094C (en) Methods and apparatus for identifying subject matter in view data
EP2422766A3 (en) Methods for preparing dry powder compositions of glycopyrrolate
MX2009005455A (es) (r)-n-estereoisomeros de analogos de 7,8-saturados-4,5 epoxi-morfinano.
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
ME01400B (en) Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
EA200800074A1 (ru) Сельскохозяйственная композиция
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
WO2007092343A3 (en) Novel epoprostenol formulation and method of making thereof
WO2004113297A3 (en) Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
IL186062A0 (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
TW200619875A (en) Compositions comprising tannic acid as corrosion inhibitor
EA200701688A1 (ru) Замещённые пирролы, содержащие их композиции, способ получения и применение
EA200701892A1 (ru) Композиции, содержащие связанную воду и компоненты, помещённые в водочувствительную основу
ITMI20040146A1 (it) Ibopamina maleato metodo per prepararlo e composizioni farmaceutiche che lo comprendono
EA200701227A1 (ru) Замещённые индолы, содержащие их композиции, способ получения и применение
TNSN07139A1 (en) 4-hydroxy tamoxifen gel formulations
ATE502003T1 (de) L-(-)-moprolol-l-(+)-tartrat
PL366975A1 (en) Pharmaceutical composition containing oxalyplatinum as well as method for its manufacture
PL112907U1 (en) Set of small containers, in particular that for displaying flower compositions